Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 241

Cannabinoids Data Safety Patients 241

MMJ Recs

FEBRUARY 6, 2024

In the ever-evolving landscape of medical marijuana, accessing cannabis through a dispensary in New Jersey can be both empowering and complex. Consumer Guide to Accessing Medical Marijuana Navigating the complexities of New Jersey’s medical marijuana program requires a comprehensive consumer guide.

Access 52

Access Dispensary Marijuana Strains 52

Medical Marijuana Program Connection

MARCH 8, 2023

Corganics, a clinical cannabinoid (CBD) company, announced a patient access partnership with OrthoLoneStar, an independent orthopedic practice in Texas. Read More

Access 52

Access Patients Therapy CBD 52

Healer

JUNE 8, 2023

With cannabis and phytocannabinoids like THC, CBD and CBG rapidly becoming highly prized therapeutic agents, many people are turning to cannabinoids for life improvement. Unfortunately, there is a lot of misinformation that can be a stumbling block to those who could truly benefit from cannabinoids like CBD and THC.

Education 40

Education Cannabinoids Programs Research and Development 40

Veriheal

MAY 18, 2023

The Study: CBD’s Effects on Nicotine Metabolism The research team at WSU embarked on a mission to investigate the specific mechanisms involved in how CBD influences nicotine metabolism, focusing on understanding how the non-intoxicating cannabinoid might aid in smoking cessation. The findings were nothing short of remarkable.

Cannabinoids 97

Cannabinoids CBD Research and Development Treatment 97

Americans for Safe Access

AUGUST 1, 2023

A New Agency – the Office of Medical Cannabis and Cannabinoid Control (OMCCC) proposed by Americans for Safe Access (ASA) By Karen Jaynes, August 1, 2023 In this past year, I have had the opportunity to dig deep into the discussions, written drafts and opinion papers of policy makers, change influencers, industry stakeholders, academics and advocates (..)

Advocacy 188

Advocacy Education Policy Cannabinoids 188

Cannabis Law Report

OCTOBER 11, 2021

This transaction will enable Comfort Leaf to launch operations as a growing Direct-to-Consumer wellness-focused cannabinoid company. Comfort Leaf’s direct-to-customer platform will enable the delivery of high-quality hemp-derived cannabinoid products at unprecedented prices. as Strategic Advisors. “We

Cannabinoids 52

Cannabinoids Supply Chain Seed-To-Sale Hemp 52

Cannabis Law Report

JULY 28, 2021

president and CEO of MJH Life Sciences™, parent company of Cannabis Patient Care ™ “We are thrilled to partner with Americans for Safe Access because we share their passion for education and for helping as many patients as we can.”.

Access 105

Access Patients Education Treatment 105

Veriheal

JUNE 22, 2021

” The doorways opening to new cannabinoid research are monumental. Over the next decade, the United States could stand to see an explosion in the research of cannabinoid therapies. Go figure the federal government chose Mississippi to be the only state where researchers can access medical cannabis legally.

DEA 59

DEA Access Therapy Cannabinoids 59

Cannabis Law Report

JULY 28, 2021

On 1 June 2021, the Group announced an agreement with Voisin Consulting SARL (“VC”), a life sciences consultancy comprising over 200 professionals in the UK, US and India, with expertise in medical devices, cannabinoids, neurological disorders and addictions.

Cannabinoids 105

Cannabinoids Clinical Trials Safety Medicine 105

Cannabis Law Report

JULY 15, 2022

The Department of Cannabis Control (Department) provided notice on June 17, 2022, of its intent to adopt regulations establishing a standard cannabinoids test method, including standardized operating procedures, that shall be utilized by all licensed testing laboratories in California. July 15, 2022. to 12:00 P.M.

Cannabinoids 52

Cannabinoids Access Law Cannabis 52

Medical Marijuana Program Connection

MAY 5, 2023

Vitality CBD V3 Complete Cannabinoid Expanding affordability, Vitality CBD launches direct-to-consumer pricing, making premium CBD accessible to Canadians. By bypassing. Read More

Access 40

Access CBD Cannabinoids 40

Canna Law Blog

DECEMBER 13, 2021

Unlike other federal legislations that have been introduced these past few years, including the Hemp Access and Consumer Safety Act ( S. The post New Federal Bill Would Regulate CBD as a Food Ingredient… But What About the Other Cannabinoids? We’ll continue to monitor these issues and will report on future developments.

Food 68

Food Cannabinoids CBD Safety 68

Project CBD

JULY 28, 2023

Project CBD: Your presentation with Allyn Howlett at the International Cannabinoid Research Society conference in Toronto (June 2023) discussed the chemical conversion of CBD into Δ8-THC (delta-8 THC) and “numerous additional THC isomers. At issue are potent, intoxicating cannabinoids other than cannabis-derived Δ9-THC.

THC 212

THC Cannabinoids Hemp Research and Development 212

Veriheal

DECEMBER 20, 2021

The cannabis plant actually produces over 150 different cannabinoids, each of which interacts with our bodies’ endocannabinoid systems differently. million donation from Leslie Buttorff, founder and CEO of CBD company Panacea Life Sciences , Colorado State University (CSU) will be taking cannabinoid research to new heights.

Cannabinoids 40

Cannabinoids THC CBD Agriculture 40

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Health Europa reports. PROGRAMME.and.ABSTRACTS.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Veriheal

AUGUST 18, 2020

K2, or Spice, is a street drug made of synthetic cannabinoids, which studies have linked to serious health problems. . Spice is one of the names frequently attached to these synthetic cannabinoids, along with the name K2. K2 is also as easily accessible as cannabis BUT it does not show up in urine drug tests.

Cannabinoids 52

Cannabinoids Blood Pressure THC Conditions 52

Cannabis Law Report

JUNE 25, 2021

According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Legal Elements Affecting Access to Medical Cannabis.

Cannabinoids 91

Cannabinoids Edibles Retail Cannabis 91

MMJ Recs

MAY 1, 2024

Through community outreach, social media campaigns, educational seminars, and mental health screenings, the month seeks to empower individuals to seek help when needed, cultivate supportive environments, and advocate for policies that promote mental health equity and access to care.

Marijuana 98

Marijuana Treatment Conditions Chronic Pain 98

SpeedWeed

MARCH 1, 2021

Despite limited access to hemp cultivation licenses in Japan, demand for CBD is on the rise,” said Shuntaro Komagata, Founder and CEO, OFF Inc. However, more than access to a steady supply, it was FireOrganix’s understanding of and ability to comply with international requirements that sealed the deal,” Shuntaro added. About OFF Inc.

Cannabinoids 52

Cannabinoids CBD Business Hemp 52

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Cannabis Law Report

SEPTEMBER 7, 2019

PRESS RELEASE: New Rochelle, NY, September 6, 2019 — Cannabis and Cannabinoid Research ( CCR ) is honored to announce that the Society of Cannabis Clinicians (SCC) has named CCR its Official Journal. The SCC is proud to announce our official partnership with the Cannabis and Cannabinoids Research Journal!

Cannabinoids 56

Cannabinoids Education Medicine Cannabis 56

MMJ Recs

JANUARY 10, 2024

Benefits of Medical Marijuana for Pain Relief The medicinal properties of marijuana, particularly its cannabinoids, have been harnessed for centuries. These cannabinoids interact with the endocannabinoid system in the human body, modulating pain perception and inflammation.

Chronic Pain 98

Chronic Pain Patients Cannabinoids Treatment 98

MMJ Recs

AUGUST 20, 2021

The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. But what does new access to medical marijuana for scientific research in the United States mean for medical marijuana development? Cannabinoid research and development. The roadblocks ahead.

Access 52

Access Research and Development Marijuana Chronic Pain 52

Veriheal

DECEMBER 19, 2023

A new delta-8 study has revealed that people in states without access to legal cannabis products are far more likely to seek out and consume delta-8 and delta-9 variants, whether it be flower, edibles, or tinctures. To learn more about your access to medical cannabis or legal products, talk to one of our doctors today.

Legalization 111

Legalization Edibles DEA Access 111

Cannabis Law Report

NOVEMBER 14, 2021

(..)

Cannabinoids 52

Cannabinoids Access Law Cannabis 52

Cannabis Law Report

OCTOBER 27, 2021

a vertically integrated provider of safe and sustainable specialty ingredients, today announced that it has successfully completed commercial-scale, fermentation-based production campaigns for its Lygos CBx cannabinoid products, including CBG (cannabigerol), CBC (cannabichromene), CBD (cannabidiol), and CBDA (cannabidiolic acid).

Cannabinoids 52

Cannabinoids Pharmaceutical Agriculture CBD 52

SpeedWeed

MARCH 21, 2021

Delta-8 THC is a minor cannabinoid that occurs naturally in cannabis plants. The 2018 Farm Bill states that all derivatives, isomers, and cannabinoids in hemp are legal, provided that the final product has less than 0.3 The post Providing Easier Access to Delta-8 THC for All appeared first on SpeedWeed. percent Delta-9 THC.

THC 52

THC Access Vaping Strains 52

Cannabis Law Report

SEPTEMBER 8, 2021

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97

Access Research and Development Medicine THC 97

Cannabis Law Report

JUNE 28, 2021

Our expertise in neurology and Curaleaf International’s knowledge of the pharmaceutical active processes of cannabinoids provide ideal conditions to bring innovative treatment to patients,” says Marco Castino, Head of Region Europe in Zambon. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

APRIL 21, 2022

Unfortunately, this appetite combined with a lack of access to regulated marijuana has perpetuated both a robust and unregulated illicit marijuana market, and an unregulated hemp industry where intoxicating hemp-derived cannabinoids like Delta-8 THC, Delta-9 THC, THC-O and HHC are freely sold directly to consumers.

Cannabinoids 52

Cannabinoids Hemp Sativa THC 52

Cannabis Law Report

OCTOBER 15, 2021

The California Legislature has passed a bill that will allow California consumers to purchase food, beverage, dietary supplements, and cosmetics manufactured with hemp-derived cannabinoids such as cannabidiol (CBD). Assembly Bill 45 (AB45), which is expected to be signed into law before Oct. No dice, said the FDA. The FDA’s response?

Food 52

Food Cannabinoids Hemp Legalization 52

Cannabis Law Report

DECEMBER 22, 2021

With growing interest in sustainable and bio-based cannabinoids, and after completing a strategic review of Hyasynth including their intellectual property (IP) and R&D platforms, Organigram remains excited about Hyasynth’s future and growth plans. million of secured convertible debentures in Hyasynth (the “Debentures”).

Cannabinoids 52

Cannabinoids Research and Development Events Pharmaceutical 52

The Joint Blog

MAY 5, 2020

PatientsAccording to a new study, access to cannabis reduces pain patients’ perceived demand for opioids. ” The full abstract can be found below: BACKGROUND: Cannabinoids may potentiate opioid analgesia and therefore could be used to reduce reliance on opioids for analgesia.

Access 49

Access Consumption Marijuana Medicine 49

The Joint Blog

AUGUST 8, 2023

In recent years, the cannabis industry has witnessed a surge of interest in the therapeutic benefits of cannabinoids. While much attention has been focused on the well-known compounds like CBD and Delta-9-THC, a lesser-known cannabinoid called Delta-8-THC has emerged as a topic of interest.

Cannabinoids 26

Cannabinoids THC Packaging Safety 26

SpeedWeed

JUNE 10, 2021

The investment will provide Flora access to extraction facilities in Malta and Portugal to process its cannabis derivatives from Colombia and distribute them through Hoshi’s channels throughout Europe. The post NFL, Players Association Provide $1 Million for Cannabinoid Research on Pain Management appeared first on SpeedWeed.

Cannabinoids 52

Cannabinoids Cultivation Supply Chain Environment 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52